Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Tong Ren Tang Technologies Co ( (HK:1666) ) is now available.
Tong Ren Tang Technologies Co. Ltd. announced its unaudited financial results for the third quarter of 2025, reporting operating revenue of approximately RMB4,979.64 million and net profits attributable to shareholders of RMB416.26 million. The announcement highlights the company’s stable financial performance, with total assets recorded at RMB14,595.89 million, reflecting its strong market position and ongoing commitment to transparency for its stakeholders.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of traditional Chinese medicine products. The company is part of the larger Beijing Tong Ren Tang Company Limited and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 1,496,749
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.02B
Learn more about 1666 stock on TipRanks’ Stock Analysis page.